The Use of Long-term Antibiotics in Bronchiectasis

Clinical Pulmonary Medicine, 03/02/2012

Bronchiectasis is a chronic and debilitating lung disease characterized by chronic daily productive cough and recurrent chest infections caused by irreversibly damaged and dilated bronchi. The condition may be progressive and lead to respiratory failure and cor pulmonale. The management of bronchiectasis is largely empirical, with few controlled clinical trials. A recent National guideline suggests that in patients having ≥3 exacerbations per year the use of long–term antibiotic therapy should be considered.

Print Article Summary Cat 2 CME Report